XML 98 R88.htm IDEA: XBRL DOCUMENT v3.2.0.727
Selected Quarterly Results of Operations Data (Unaudited) - Consolidating statement of operations (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2015
Mar. 31, 2015
 [1]
Dec. 31, 2014
 [2]
Sep. 30, 2014
 [2]
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
Condensed Income Statements, Captions [Line Items]                      
Total net sales $ 184,950 $ 187,495 $ 188,688 $ 187,458 $ 183,677 $ 173,267 $ 172,742 $ 162,228 $ 748,591 $ 691,914 $ 653,151
Cost of goods sold 124,102 128,385 132,603 127,129 129,412 120,425 121,586 112,716 512,219 484,139 474,187
Gross profit 60,848 59,110 56,085 60,329 54,265 52,842 51,156 49,512 236,372 207,775 178,964
Selling, general and administrative expenses 39,885 37,297 36,298 35,224 41,208 35,520 34,138 33,115 148,704 143,981 122,233
Operating income (loss) 20,963 21,813 19,787 25,105 13,057 17,322 17,018 16,397 87,668 63,794 56,731
Interest expense, net 3,698 3,602 3,515 3,490 6,764 8,744 8,719 8,735 14,305 32,962  
Foreign currency (gains) losses, net 1,455 (4,633) (1,018) (1,204) (335) 275 1,165 648 (5,400) 1,753 3,103
Loss on extinguishment of debt         22,771         22,771  
Income (loss) before income taxes 15,810 22,844 17,290 22,819 (16,143) 8,303 7,134 7,014 78,763 6,308 17,848
Provision (benefit) for income taxes 5,406 6,148 3,042 3,887 1,499 1,933 4,832 1,171 18,483 9,435 (7,043)
Net income (loss) $ 10,404 $ 16,696 $ 14,248 $ 18,932 $ (17,642) $ 6,370 $ 2,302 $ 5,843 $ 60,280 $ (3,127) $ 24,891
Net income per share                      
basic (in dollars per share) $ 0.27 $ 0.43 $ 0.37 $ 0.49         $ 1.55 $ (0.10) $ 0.82
diluted (in dollars per share) $ 0.26 $ 0.42 $ 0.36 $ 0.48         $ 1.51 (0.10) $ 0.82
Net income per share - basic and diluted (in dollars per share)         $ (0.47) $ 0.21 $ 0.08 $ 0.19   $ (0.10)  
Adjusted EBITDA                      
Adjusted EBITDA $ 27,037 $ 27,496 $ 25,028 $ 30,458 $ 24,245 $ 22,444 $ 22,310 $ 21,598 $ 110,019 $ 90,597 $ 75,754
Reconciliation of Adjusted EBITDA to income before income taxes                      
Adjusted EBITDA 27,037 27,496 25,028 30,458 24,245 22,444 22,310 21,598 110,019 90,597 75,754
Depreciation and amortization (5,654) (5,356) $ (5,241) $ (5,353) (5,838) (5,122) (5,292) (5,201) $ (21,604) (21,453) $ (19,023)
Loss on insurance claim         (5,350)         (5,350)  
Acquisition related accrued compensation (420) (327)             $ (747)    
Interest expense, net (3,698) (3,602) $ (3,515) $ (3,490) (6,764) (8,744) (8,719) (8,735) (14,305) (32,962) $ (35,629)
Foreign currency gains (losses), net (1,455) 4,633 1,018 1,204 335 (275) (1,165) (648) 5,400 (1,753) (3,103)
Loss on extinguishment of debt         (22,771)         (22,771)  
Income before income taxes 15,810 22,844 17,290 22,819 (16,143) 8,303 7,134 7,014 78,763 6,308 17,848
Operating Segments | Animal Health                      
Condensed Income Statements, Captions [Line Items]                      
Total net sales 117,444 117,346 118,785 117,225 114,108 107,808 107,966 101,171 470,800 431,053 384,941
Adjusted EBITDA                      
Adjusted EBITDA 29,880 29,629 28,296 32,454 26,146 25,505 24,522 24,107 120,259 100,280 82,997
Reconciliation of Adjusted EBITDA to income before income taxes                      
Adjusted EBITDA 29,880 29,629 28,296 32,454 26,146 25,505 24,522 24,107 120,259 100,280 82,997
Depreciation and amortization                 (15,430) (15,484) (13,907)
Operating Segments | Mineral Nutrition                      
Condensed Income Statements, Captions [Line Items]                      
Total net sales 55,593 57,320 58,742 55,447 54,879 49,901 50,633 46,186 227,102 201,599 203,169
Adjusted EBITDA                      
Adjusted EBITDA 3,435 3,761 3,754 3,479 3,491 2,807 2,878 2,460 14,429 11,636 12,069
Reconciliation of Adjusted EBITDA to income before income taxes                      
Adjusted EBITDA 3,435 3,761 3,754 3,479 3,491 2,807 2,878 2,460 14,429 11,636 12,069
Depreciation and amortization                 (2,468) (2,368) (2,275)
Operating Segments | Performance Products                      
Condensed Income Statements, Captions [Line Items]                      
Total net sales 11,913 12,829 11,161 14,786 14,690 15,558 14,143 14,871 50,689 59,262 65,041
Adjusted EBITDA                      
Adjusted EBITDA 454 994 162 1,036 1,521 906 1,103 1,096 2,646 4,626 2,927
Reconciliation of Adjusted EBITDA to income before income taxes                      
Adjusted EBITDA 454 994 162 1,036 1,521 906 1,103 1,096 2,646 4,626 2,927
Depreciation and amortization                 (577) (412) (242)
Corporate                      
Adjusted EBITDA                      
Adjusted EBITDA (6,732) (6,888) (7,184) (6,511) (6,913) (6,774) (6,193) (6,065) (27,315) (25,945) (22,239)
Reconciliation of Adjusted EBITDA to income before income taxes                      
Adjusted EBITDA $ (6,732) $ (6,888) $ (7,184) $ (6,511) $ (6,913) $ (6,774) $ (6,193) $ (6,065) (27,315) (25,945) (22,239)
Depreciation and amortization                 $ (3,129) $ (3,189) $ (2,599)
[1] (Restated)
[2] (Revised)